P. Schwarzenberger et al., Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis, J IMMUNOL, 164(9), 2000, pp. 4783-4789
IL-17 is a novel, CD4(+) T cell-restricted cytokine. In vivo, it stimulates
hematopoiesis and causes neutrophilia consisting of mature granulocytes. I
n this study, we show that IL-17-mediated granulopoiesis requires G-CSF rel
ease and the presence or induction of the transmembrane form of stem cell f
actor (SCF) for optimal granulopoiesis. However, IL-17 also protects mice f
rom G-CSF neutralization-induced neutropenia, G-CSF neutralization complete
ly reversed IL-17-induced BM progenitor expansion, whereas splenic CFU-GM/C
FU-granulocyte-erythrocyte-megakaryocyte-monocyte was only reduced by 50% i
n both Sl/Sld and littermate control mice. Thus, there remained a significa
nt SCF/G-CSF-independent effect of IL-17 on splenic granulopoiesis, resulti
ng in a preservation of mature circulating granulocytes. IL-17 is a cytokin
e that potentially interconnects lymphocytic and myeloid host defense and m
ay have potential for therapeutic development.